255 related articles for article (PubMed ID: 32390300)
21. Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors.
Xie F; Liang Y; Xia Y; Luo S; Jiang F; Fu L
Bioorg Chem; 2019 Nov; 92():103273. PubMed ID: 31539748
[TBL] [Abstract][Full Text] [Related]
22. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
[TBL] [Abstract][Full Text] [Related]
23. Combined Ligand- and Receptor-Based Virtual Screening Methodology to Identify Structurally Diverse Protein Tyrosine Phosphatase 1B Inhibitors.
Gimeno A; Ardid-Ruiz A; Ojeda-Montes MJ; Tomás-Hernández S; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Valls C; Aragonès G; Suárez M; Pujadas G; Garcia-Vallvé S
ChemMedChem; 2018 Sep; 13(18):1939-1948. PubMed ID: 30024103
[TBL] [Abstract][Full Text] [Related]
24. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
Wang Z; Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3337-40. PubMed ID: 24953600
[TBL] [Abstract][Full Text] [Related]
27. Discovery of di-indolinone as a novel scaffold for protein tyrosine phosphatase 1B inhibitors.
Dai HL; Gao LX; Yang Y; Li JY; Cheng JG; Li J; Wen R; Peng YQ; Zheng JB
Bioorg Med Chem Lett; 2012 Dec; 22(24):7440-3. PubMed ID: 23122522
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604
[TBL] [Abstract][Full Text] [Related]
29. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
SarathKumar B; Lakshmi BS
J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
Jiang B; Guo S; Shi D; Guo C; Wang T
Eur J Med Chem; 2013 Jun; 64():129-36. PubMed ID: 23644196
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
32. In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors.
Mahapatra MK; Bera K; Singh DV; Kumar R; Kumar M
J Biomol Struct Dyn; 2018 Apr; 36(5):1195-1211. PubMed ID: 28393626
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
Jin J; Ye X; Boateng D; Dai K; Ye F; Du P; Yu H
Bioorg Med Chem Lett; 2019 Aug; 29(16):2358-2363. PubMed ID: 31221555
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel PTP1B inhibitors with antihyperglycemic activity.
Liu Z; Chai Q; Li YY; Shen Q; Ma LP; Zhang LN; Wang X; Sheng L; Li JY; Li J; Shen JK
Acta Pharmacol Sin; 2010 Aug; 31(8):1005-12. PubMed ID: 20686525
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
Gupta S; Pandey G; Rahuja N; Srivastava AK; Saxena AK
Bioorg Med Chem Lett; 2010 Oct; 20(19):5732-4. PubMed ID: 20797859
[TBL] [Abstract][Full Text] [Related]
37. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity.
Rocha RF; Rodrigues T; Menegatti ACO; Bernardes GJL; Terenzi H
Bioorg Chem; 2020 Jul; 100():103927. PubMed ID: 32422389
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Mahapatra MK; Kumar R; Kumar M
Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
[TBL] [Abstract][Full Text] [Related]
39. Identification of natural products as selective PTP1B inhibitors via virtual screening.
Yang Y; Tian JY; Ye F; Xiao Z
Bioorg Chem; 2020 May; 98():103706. PubMed ID: 32199302
[TBL] [Abstract][Full Text] [Related]
40. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]